BIO names exec VP-health
Executive Summary
Former FDA Deputy Commissioner for Policy Amit Sachdev joins the Biotechnology Industry Organization as executive VP for health April 18. Sachdev left FDA March 25. BIO is finalizing the details of a new top-level organizational structure, with an announcement expected the week of April 18. The association also has named former House Energy & Commerce Committee Majority Counsel Brent Delmonte as VP for legislative affairs and former HHS Chief of Staff Scott Whitaker as CEO Jim Greenwood's second-in-command (1"The Pink Sheet" April 11, 2005, In Brief)...
You may also be interested in...
BIO appoints second-in-command
Biotechnology Industry Organization is finalizing a title for former HHS Chief of Staff Scott Whitaker, who recently joined BIO as the number two executive under CEO James Greenwood (1"The Pink Sheet" Feb. 21, 2005, In Brief). Although BIO says Whitaker's official title has not yet been finalized, the group's website identifies Whitaker as the executive vice president. At a recent Center for Global Development meeting at Covington & Burling in Washington, D.C., Whitaker was introduced as BIO's exec VP and chief operating officer...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.